FORM 8-A


                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                               ------------------

                FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
                     PURSUANT TO SECTION 12(b) OR (g) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


                          BIO-TECHNOLOGY GENERAL CORP.
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


          Delaware                                             13-3033811    
- -------------------------------                            ------------------
 (State of incorporation                                   (I.R.S. Employer
   or organization)                                       Identification Number)


   70 Wood Avenue South, Iselin, New Jersey                      08830
- -------------------------------------------------          ------------------
   (Address of principal executive offices)                   (Zip Code)


       SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:


Title of Each Class                          Name of Each Exchange on Which
to be so Registered                          Each Class is to be Registered
- -------------------                          ------------------------------
   Not Applicable                                   Not Applicable



If this Form relates to the registration of a class of debt securities and
is effective upon filing pursuant to General Instruction A.(c)(1), please
check the following box.                                                     |_|

If this Form relates to the registration of a class of debt securities and
is to become effective simultaneously with the effectiveness of a
concurrent registration statement under the Securities Act of 1933 pursuant
to General Instruction A.(c)(2), please check the following box.             |_|



     SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:


                 Class B Warrants to Purchase Common Stock
- --------------------------------------------------------------------------------
                               Title of Class


Item 1.  Description of Registrant's Securities to be Registered

     A description of the Class B Warrants is set forth on pages 16 and 17 of
the Prospectus forming part of the Registration Statement on Form S-3 filed
under the Securities Act of 1933, as amended (the "Act"), with the Securities
and Exchange Commission on April 19, 1996, Registration No. 333-2685 (the
"Registration Statement") on behalf of Bio-Technology General Corp. (the
"Registrant"), which is hereby incorporated by reference for all purposes.


Item 2.  Exhibits

     1.   Certificate of Incorporation of the Registrant, incorporated herein by
          reference to Exhibit 3(a) of the Company's quarterly report on Form
          10-Q for the quarter ended June 30, 1994.

     2.   By-Laws of the Registrant, incorporated herein by reference to Exhibit
          3(b) of the Company's quarterly report on Form 10-Q for the quarter
          ended September 30, 1994.

     3.   Specimen Class B Warrant Certificate of the Registrant, incorporated
          herein by reference to Exhibit 4(b) of the Registration Statement.

     The Registrant hereby further incorporates by reference the description of
the Class B Warrants included in any form of prospectus subsequently filed by
the Registrant pursuant to Rule 424(b) under the Act.


                                       -2-



                                    SIGNATURE


     Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Registrant has duly caused this Registration Statement to be signed
on its behalf by the undersigned, thereto duly authorized.


                                           BIO-TECHNOLOGY GENERAL CORP.



                                           By /s/ Yehuda Sternlicht
                                              --------------------------
                                              Yehuda Sternlicht
                                              Vice President-Finance and
                                                Chief Financial Officer


Dated:   April 19, 1996




                                       -3-